People: Nektar Therapeutics (NKTR.O)

NKTR.O on Nasdaq

11.71USD
9 Feb 2010
Price Change (% chg)

$0.31 (+2.72%)
Prev Close
$11.71
Open
--
Day's High
$11.76
Day's Low
$11.40
Volume
611,817
Avg. Vol
608,368
52-wk High
$12.28
52-wk Low
$4.00

view people for:

Kuebler, Christopher 

Brief Biography

Mr. Christopher A. Kuebler has served as Director of Nektar Therapeutics since December 2001. Mr. Kuebler also currently serves on the board of directors of Waters Corporation, an analytical technologies services company. From January 1997 to December 2005, Mr. Kuebler served as Chairman of the Board of Covance Inc., a drug development services company, and from November 1994 to December 2004, served as its Chief Executive Officer. From March 1993 through November 1994, he was the Corporate Vice President, European Operations for Abbott Laboratories, a diversified health care company. From January 1986 until March 1993, Mr. Kuebler served in various commercial positions for Abbott Laboratories’ Pharmaceutical Division and was that Division’s Vice President, Sales and Marketing prior to taking the position of Corporate Vice President, European Operations. Before that, he held positions at Squibb Inc. and Monsanto Health Care. Mr. Kuebler holds a B.S. in Biological Science from Florida State University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total
Chess, Robert 1,468,750
Robin, Howard 2,149,090
Nicholson, John 1,309,800
Chowrira, Bharatt 951,161
Doberstein, Stephen --
Labrucherie, Gil 1,175,970
As Of 30 Dec 2008
view people for: